녹내장 치료 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)
Glaucoma Treatment Market [Product Type: Prostaglandin Analogs (PGAs), Alpha Agonist, Beta Blockers, Cholinergic, Carbonic Anhydrase Inhibitors, Combined Medications] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
상품코드:1420990
리서치사:Transparency Market Research
발행일:2023년 12월
페이지 정보:영문 170 Pages
라이선스 & 가격 (부가세 별도)
한글목차
녹내장 치료 시장 - 리포트의 범위
세계의 녹내장 치료 시장에 관한 TMR의 리포트는 과거와 현재의 성장 동향 및 2023-2031년의 예측 기간 중 시장 지표의 귀중한 인사이트를 얻을 기회를 연구하고 있습니다. 이 리포트는 세계의 녹내장 치료 시장 매출을 제공하고, 2017-2031년의 기간, 2023년을 기준년, 2031년을 예측년으로 간주합니다. 이 리포트는 2023-2031년 세계의 녹내장 치료 시장의 연평균 성장률(CAGR %)도 제공합니다.
이 리포트는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 조사 활동의 대부분이 시행되고, 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 제조업체와 인터뷰를 시행했습니다. 2차 조사에는 녹내장 치료 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차보고서, 프레스 릴리스 및 관련 문서의 참조가 포함됩니다.
시장 스냅숏
2023년 시장 가치
63억 달러
2031년 시장 가치
91억 달러
CAGR
4.3%
이 리포트는 세계의 녹내장 치료 시장의 경쟁 구도를 상세히 파악하고 있습니다. 세계의 녹내장 치료 시장에서 활동하는 주요 기업이 식별되고, 각각의 기업이 다양한 속성의 관점으로부터 프로파일링되고 있습니다. 회사 개요, 재무 상황, 최근 동향, SWOT는 이 리포트에서 소개되고 있는 세계의 녹내장 치료 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장의 분석과 예측, 2023-2031년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 합병과 인수
COVID-19 팬데믹이 업계에 미치는 영향
제6장 세계 시장의 분석과 예측 : 제품 유형별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 제품 유형별, 2023-2031
프로스타글란딘 유사체(PGA)
알파 아고니스트
베타 브로커
콜린작용제
탄산탈수소효소 저해제
병용약
시장의 매력 분석 : 제품 유형별
제7장 세계 시장의 분석과 예측 : 적응증별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 적응증별, 2023-2031
폐색각 녹내장(ACG)
개방각 녹내장(OAG)
이차 녹내장
선천성 녹내장
기타
시장의 매력 분석 : 적응증별
제8장 세계 시장의 분석과 예측 : 판매채널별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 판매채널별, 2023-2031
병원 약국
소매 약국
온라인 판매
시장의 매력 분석 : 판매채널별
제9장 세계 시장의 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별, 2023-2031
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 분석 : 지역별
제10장 북미 시장 분석과 예측
제11장 유럽 시장 분석과 예측
제12장 아시아태평양 시장 분석과 예측
제13장 라틴아메리카 시장 분석과 예측
제14장 중동 및 아프리카 시장 분석과 예측
제15장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업의 계층 및 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
Novartis AG
Pfizer, Inc.
Merck &Co., Inc.
Bausch &Lomb Inc.
Allergan Plc
Perrigo Plc
Teva Pharmaceutical Industries Ltd.
Akorn, Inc.
Mobius Therapeutics, LLC
KSA
영문 목차
영문목차
Glaucoma Treatment Market - Scope of Report
TMR's report on the global glaucoma treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global glaucoma treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global glaucoma treatment market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the glaucoma treatment market.
Market Snapshot
Market Value in 2023
US$ 6.3 Bn
Market Value in 2031
US$ 9.1 Bn
CAGR
4.3%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global glaucoma treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global glaucoma treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global glaucoma treatment market.
The report delves into the competitive landscape of the global glaucoma treatment market. Key players operating in the global glaucoma treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global glaucoma treatment market profiled in this report.
Key Questions Answered in Global glaucoma treatment Market Report:
What is the sales/revenue generated by glaucoma treatment across all regions during the forecast period?
What are the opportunities in the global glaucoma treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Glaucoma Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global glaucoma treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global glaucoma treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global glaucoma treatment market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Glaucoma Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Glaucoma Treatment Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Glaucoma Treatment Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2023-2031
6.3.1. Prostaglandin Analogs (PGAs)
6.3.2. Alpha Agonist
6.3.3. Beta Blockers
6.3.4. Cholinergic
6.3.5. Carbonic Anhydrase Inhibitors
6.3.6. Combined Medications
6.4. Market Attractiveness Analysis, by Product Type
7. Global Glaucoma Treatment Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication, 2023-2031
7.3.1. Angle Closure Glaucoma (ACG)
7.3.2. Open Angle Glaucoma (OAG)
7.3.3. Secondary Glaucoma
7.3.4. Congenital Glaucoma
7.3.5. Other Indications
7.4. Market Attractiveness Analysis, by Indication
8. Global Glaucoma Treatment Market Analysis and Forecast, by Sales Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Sales Channel, 2023-2031
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Sales
8.4. Market Attractiveness Analysis, by Sales Channel
9. Global Glaucoma Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Glaucoma Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2023-2031
10.3.1. Prostaglandin Analogs (PGAs)
10.3.2. Alpha Agonist
10.3.3. Beta Blockers
10.3.4. Cholinergic
10.3.5. Carbonic Anhydrase Inhibitors
10.3.6. Combined Medications
10.4. Market Value Forecast, by Indication, 2023-2031
10.4.1. Angle Closure Glaucoma (ACG)
10.4.2. Open Angle Glaucoma (OAG)
10.4.3. Secondary Glaucoma
10.4.4. Congenital Glaucoma
10.4.5. Other Indications
10.5. Market Value Forecast, by Sales Channel, 2023-2031
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Online Sales
10.6. Market Value Forecast, by Country, 2023-2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Indication
10.7.3. By Sales Channel
10.7.4. By Country
11. Europe Glaucoma Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2023-2031
11.3.1. Prostaglandin Analogs (PGAs)
11.3.2. Alpha Agonist
11.3.3. Beta Blockers
11.3.4. Cholinergic
11.3.5. Carbonic Anhydrase Inhibitors
11.3.6. Combined Medications
11.4. Market Value Forecast, by Indication, 2023-2031
11.4.1. Angle Closure Glaucoma (ACG)
11.4.2. Open Angle Glaucoma (OAG)
11.4.3. Secondary Glaucoma
11.4.4. Congenital Glaucoma
11.4.5. Other Indications
11.5. Market Value Forecast, by Sales Channel, 2023-2031
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Sales
11.6. Market Value Forecast, by Country/Sub-region, 2023-2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Indication
11.7.3. By Sales Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Glaucoma Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2023-2031
12.3.1. Prostaglandin Analogs (PGAs)
12.3.2. Alpha Agonist
12.3.3. Beta Blockers
12.3.4. Cholinergic
12.3.5. Carbonic Anhydrase Inhibitors
12.3.6. Combined Medications
12.4. Market Value Forecast, by Indication, 2023-2031
12.4.1. Angle Closure Glaucoma (ACG)
12.4.2. Open Angle Glaucoma (OAG)
12.4.3. Secondary Glaucoma
12.4.4. Congenital Glaucoma
12.4.5. Other Indications
12.5. Market Value Forecast, by Sales Channel, 2023-2031
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Sales
12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Indication
12.7.3. By Sales Channel
12.7.4. By Country/Sub-region
13. Latin America Glaucoma Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2023-2031
13.3.1. Prostaglandin Analogs (PGAs)
13.3.2. Alpha Agonist
13.3.3. Beta Blockers
13.3.4. Cholinergic
13.3.5. Carbonic Anhydrase Inhibitors
13.3.6. Combined Medications
13.4. Market Value Forecast, by Indication, 2023-2031
13.4.1. Angle Closure Glaucoma (ACG)
13.4.2. Open Angle Glaucoma (OAG)
13.4.3. Secondary Glaucoma
13.4.4. Congenital Glaucoma
13.4.5. Other Indications
13.5. Market Value Forecast, by Sales Channel, 2023-2031
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Sales
13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Indication
13.7.3. By Sales Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Glaucoma Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2023-2031
14.3.1. Prostaglandin Analogs (PGAs)
14.3.2. Alpha Agonist
14.3.3. Beta Blockers
14.3.4. Cholinergic
14.3.5. Carbonic Anhydrase Inhibitors
14.3.6. Combined Medications
14.4. Market Value Forecast, by Indication, 2023-2031
14.4.1. Angle Closure Glaucoma (ACG)
14.4.2. Open Angle Glaucoma (OAG)
14.4.3. Secondary Glaucoma
14.4.4. Congenital Glaucoma
14.4.5. Other Indications
14.5. Market Value Forecast, by Sales Channel, 2023-2031
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Sales
14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Indication
14.7.3. By Sales Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
